Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Discoidin domain-containing tyrosine-protein kinase 2 (DDR2) is a receptor tyrosine kinase activated by fibrillar collagens. It plays a crucial role in cell differentiation, proliferation, migration, and extracellular matrix remodeling. DDR2 dysregulation is implicated in fibrosis, cancer progression, and arthritis, making it a promising therapeutic target.
Tyrosine kinase inhibitor; targets DDR2 autophosphorylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Discoidin domain-containing tyrosine-protein kinase (DDR2).